Treatment of large plasma volumes using specific immunoadsorption to desensitize ABO-incompatible kidney-transplant candidates

Lionel Rostaing ^1,2,3 * , Asma Allal ¹, Arnaud del Bello ¹, Federico Sallusto ⁴, Laure Esposito ¹, Nicolas Doumerc ⁴, Bénédicte Debiol ⁵, Audrey Delas ⁶, Xavier Game ^3,4, Nassim Kamar ^1,3,7

Cited by CrossRef: 17

1- Orlowski A, Katz M, Gubara S, Fargnoli A, Fish K, Weber T. Successful Transduction with AAV Vectors after Selective Depletion of Anti-AAV Antibodies by Immunoadsorption. Molecular Therapy - Methods & Clinical Development. 2020;16:192 [Crossref]

2- Tiwari V, Gupta A, Divyaveer S, Bhargava V, Malik M, Gupta A, Bhalla A, Rana D. Immunoadsorption column reuse. Indian J Nephrol. 2021;31(1):33 [Crossref]

3- Mohamed M, Sweeney T, Alkhader D, Nassar M, Alqassieh A, Lakhdar S, Nso N, Fülöp T, Daoud A, Soliman K. ABO incompatibility in renal transplantation. WJT. 2021;11(9):388 [Crossref]

4- Fernández Rivera C, Calvo Rodríguez M, López Muñíz A, Ferreiro Hermida T, Seijo Bestilleiro R, Andón Saavedra C, Galego García A, Alonso Hernández A. Trasplante renal de donante vivo ABO incompatible. Estudio de 48 pacientes tras desensibilización. Nefrología. 2019;39(6):612 [Crossref]

5- Maurizi-Balzan J, Jouve T, Naciri-Bennani H, Noble J, Tanoukhi K, Motte L, Malvezzi P, Rostaing L. Comment mettre en place un plateau technique d’aphérèses. Néphrologie & Thérapeutique. 2019;15(6):439 [Crossref]

6- Uchida J, Kosoku A, Naganuma T, Tanaka T, Nakatani T. Latest insights on ABO‐incompatible living‐donor renal transplantation. Int J of Urology. 2020;27(1):30 [Crossref]

7- Lozano M, Cid J. How do we forecast tomorrows’ transfusion: Non-transfusional hemotherapy. Transfusion Clinique et Biologique. 2023;30(2):282 [Crossref]

8- Garraud O. Therapeutic plasma exchange, 2019 and beyond. Transfusion and Apheresis Science. 2019;58(3):226 [Crossref]

9- Rivera C, Rodríguez M, Muñíz A, Hermida T, Bestilleiro R, Saavedra C, García A, Hernández A. ABO incompatible live donor renal transplant. Study of 48 patients after desensitization. Nefrología (English Edition). 2019;39(6):612 [Crossref]

10- Yagisawa T, Kanzawa T, Fujiwara Y, Banno T, Saito A, Oki R, Unagami K, Hirai T, Omoto K, Hanafusa N, Ishida H, Takagi T. Comparison of estimated blood loss during living kidney transplantation according to the number of double-filtration plasmapheresis. Ren Replace Ther. 2024;10(1) [Crossref]

11- Rana D, Bhalla A, Gupta A, Malik M, Gupta A. Enhancing Success in the ABO-Incompatible Kidney Transplantation: A Case Report. 2024; [Crossref]

12- Cen M, Wang R, Kong W, Deng H, Lei W, Chen J. ABO‐incompatible living kidney transplantation. Clinical Transplantation. 2020;34(9) [Crossref]

13- Fuchs K, Rummler S, Ries W, Helmschrott M, Selbach J, Ernst F, Morath C, Gauly A, Atiye S, Stauss‐Grabo M, Giefer M. Performance, clinical effectiveness, and safety of immunoadsorption in a wide range of indications. Ther Apher Dial. 2022;26(1):229 [Crossref]

14- Hanaoka A, Naganuma T, Takemoto Y, Uchida J, Nakatani T, Kabata D, Shintani A. Efficacy of selective plasma exchange as pre-transplant apheresis in ABO-incompatible kidney transplantation. Ren Replace Ther. 2019;5(1) [Crossref]

15- Hanaoka A, Naganuma T, Kabata D, Takemoto Y, Uchida J, Nakatani T, Shintani A. Selective plasma exchange in ABO-incompatible kidney transplantation: comparison of substitution with albumin and partial substitution with fresh frozen plasma. Sci Rep. 2020;10(1) [Crossref]

16- Naciri Bennani H, Noble J, Chevallier E, Terrec F, Motte L, Giroux‐Lathuile C, Bugnazet M, Imerzoukene F, Janbon B, Malvezzi P, Rostaing L, Jouve T. Isoagglutinin removal by plasma centrifugation or filtration (single or double): A prospective study in a single center. J of Clinical Apheresis. 2021;36(1):149 [Crossref]

17- Naciri Bennani H, Bobo Barry K, Noble J, Malvezzi P, Jouve T, Rostaing L. Outcomes of ABO-incompatible kidney transplants with very high isoagglutinin titers: a single-center experience and literature review. Front Immunol. 2024;15 [Crossref]